Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.1K
Autoimmune Disorders01:29

Autoimmune Disorders

904
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
904

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registry.

Reumatologia clinica·2025
Same author

High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients.

Journal of autoimmunity·2020
Same author

Comment on: Reclassification into very-high cardiovascular risk in psoriatic arthritis as well as axial spondyloarthritis.

Clinical and experimental rheumatology·2020
Same author

Spontaneous coronary artery dissection in systemic lupus erythematosus: case-based review.

Rheumatology international·2019
Same author

Muscular Hydatidosis Mimicking Lipoma.

The Journal of rheumatology·2018
Same author

Carbamazepine-induced systemic lupus erythematosus: A case-based review.

European journal of rheumatology·2018

Related Experiment Video

Updated: Oct 21, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.3K

Giant cell arteritis with spontaneous remission.

Bonifacio Álvarez-Lario1, José Andrés Lorenzo-Martín1, María Colazo-Burlato1

  • 1Rheumatology Department, Hospital Universitario de Burgos, Burgos, Spain.

Modern Rheumatology Case Reports
|September 7, 2021
PubMed
Summary

Polymyalgia rheumatica (PMR) can progress to giant cell arteritis (GCA) years later. This case highlights GCA

Keywords:
Giant cell arteritispolymyalgia rheumaticaspontaneous remissiontemporal arteritistemporal artery biopsy complications

More Related Videos

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

443
Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice
08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Published on: January 31, 2020

7.0K

Related Experiment Videos

Last Updated: Oct 21, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.3K
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

443
Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice
08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Published on: January 31, 2020

7.0K

Area of Science:

  • Rheumatology
  • Internal Medicine

Background:

  • Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are common in older adults.
  • PMR and GCA often coexist and share inflammatory pathways.

Observation:

  • A 75-year-old woman with PMR in remission developed GCA symptoms including headache and diplopia.
  • Symptoms spontaneously resolved, but ultrasound showed temporal artery abnormalities.
  • A temporal artery biopsy was unsuccessful and complicated by facial nerve injury.

Findings:

  • Diagnosis of GCA was confirmed by clinical, laboratory, and ultrasound findings.
  • The patient achieved remission with prednisone and methotrexate treatment.
  • The case presents spontaneous GCA remission and diagnostic challenges.

Implications:

  • This case underscores the importance of monitoring PMR patients for GCA development.
  • It highlights diagnostic difficulties and potential complications of temporal artery biopsy.
  • The case contributes to understanding GCA's varied clinical presentations and management.